BioSpace News Archive

Causaly, the AI company teaching computers to read, understand and interpret biomedical knowledge, is pleased to announce its series A fundraising round, which saw new and existing investors commit $4.8m into the company.

Vertex Pharmaceuticals Incorporated announced that the French Authorities have approved national reimbursement of ORKAMBI® for people ages two and older with cystic fibrosis who have two copies of the F508del mutation in the cystic fibrosis transmembrane conductance regulator gene.

Exagen Inc. announced that Ron Rocca, CEO of Exagen, will be participating in the 31st Annual Piper Jaffray Healthcare Conference on Thursday, December 5 in New York City.

PatientPop, the leader in healthcare practice growth technology, today announced Nick Bellomo as Chief Financial Officer.

The need for surface disinfection is reaching a critical point with flu cases already being reported across Canada by FluWatch surveillance.

IDEAYA Biosciences, Inc. (Nasdaq: IDYA), an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics to treat cancer, announced it has presented data from an ongoing Phase 1/2 clinical trial entitled “A Phase 1/2 Study in Patients with Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions”

Baylis Medical announced today the first Arctic Front™ Advance Cryoballoon procedures performed using the VersaCross Transseptal Solution

Sanofi announced an enterprise-wide collaboration with health care technology company Aetion that will integrate Sanofi’s real-world data platform, DARWIN, with the Aetion Evidence Platform® with the objective of advancing more efficient use of real-world evidence, facilitating regulatory-grade studies with deep transparency, and unlocking access to new real-world data.

LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced it is ending its Caisson Transcatheter Mitral Valve Replacement (TMVR) program and will undertake a restructuring of its heart valve business to improve profitability and ensure business continuity.

Freyr Solutions, a leading Regulatory solutions and services provider, has unveiled a pathbreaking labeling platform – Freyr LABEL 360.